Concepedia

Tatevik Ghukasyan Lakic

TG

13

Publications

604

Citations

12

H-Index

2016

Active since

Affiliations

Uppsala University(Current)

University of Sheffield

AstraZeneca (Sweden)

University of Cincinnati Medical Center

Stavanger University Hospital

Tatevik Ghukasyan Lakic is an author at Uppsala University specializing in public health, medicine, and cardiovascular disease.

ORCID

Top concepts

Publications per year

2016–2022

13

Publications

13

Which factors are most predictive for live birth after in vitro fertilization and intracytoplasmic sperm injection (IVF/ICSI) treatments? Analysis of 100 prospectively recorded variables in 8,400 IVF/ICSI single-embryo transfers

Katarina Kebbon Vaegter, Tatevik Ghukasyan Lakic, Matts Olovsson et al. · Fertility and Sterility · 2017 · 203 citations

, , +14

Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome

Gorav Batra, Tatevik Ghukasyan Lakic, Johan Lindbäck et al. · JAMA Cardiology · 2021 · 103 citations · Full text

Prediction of Residual Risk by Ceramide‐Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy

Mika Hilvo, Lars Wallentin, Tatevik Ghukasyan Lakic et al. · Journal of the American Heart Association · 2020 · 60 citations · Full text

Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y <sub>12</sub> Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial

Francesco Franchi, Stefan James, Tatevik Ghukasyan Lakic et al. · Journal of the American Heart Association · 2019 · 47 citations · Full text

C-X-C Ligand 16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary Syndromes

Thomas T. Andersen, Thor Ueland, Tatevik Ghukasyan Lakic et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2019 · 32 citations · Full text

Rows per page

1–5 of 13